Global Information
회사소개 | 문의

유럽의 자궁경부암 검사 시장 : 검사 종류별(자궁경부 세포검사, HPV DNA), 국가별 시장 규모 및 진찰자수 예측

Europe Cervical Cancer Diagnostics Market & Forecast, By Test Type (Pap smear & HPV DNA) & Countries

리서치사 Renub Research
발행일 2018년 06월 상품 코드 427204
페이지 정보 영문 163 Pages
가격
US $ 1,290 ₩ 1,465,000 Unprintable PDF by E-mail (Single User License)
US $ 1,790 ₩ 2,034,000 Hard Copy Mail Delivery help
Hard Copy의 형태로 우편 배송됩니다. PDF 파일도 함께 제공되며 PDF 파일은 인쇄가 불가능합니다.
US $ 1,790 ₩ 2,034,000 PDF by E-mail (2-5 User License)
US $ 2,290 ₩ 2,602,000 PDF by E-mail (Multi User License) help
동일 기업 내의 모든 직원들이 이용할 수 있는 라이선스입니다. 편집은 불가능하며 인쇄 횟수에 제한은 없습니다.

주의 : 본 보고서는 PDF 파일 이용 시 라이선스에 따라 보고서 인쇄가 제한됩니다.
Single User License 구입 시에는 인쇄가 불가능하므로 이용에 주의하시기 바랍니다.



유럽의 자궁경부암 검사 시장 : 검사 종류별(자궁경부 세포검사, HPV DNA), 국가별 시장 규모 및 진찰자수 예측 Europe Cervical Cancer Diagnostics Market & Forecast, By Test Type (Pap smear & HPV DNA) & Countries
발행일 : 2018년 06월 페이지 정보 : 영문 163 Pages

유럽의 자궁경부암 검사(Cervical Cancer Test) 시장을 조사했으며, 유럽 전체 및 주요 국가별 진찰자수 추이와 예측, 시장 규모 추이와 예측, 검사별 분석, 시장 점유율, 시장 성장 촉진요인 및 저해요인 등의 정보를 정리하여 전해드립니다.

제1장 주요 요약

제2장 유럽의 자궁경부암 검사(스크리닝) 진찰자수와 예측

제3장 유럽의 자궁경부암 검사(스크리닝) 시장과 예측

  • 자궁경부 세포검사(Pap Smear Test)
  • HPV DNA 검사

제4장 유럽의 자궁경부암 검사(스크리닝) 진찰자 및 시장 점유율과 예측

  • 진찰자 점유율과 예측
  • 시장 점유율과 예측
  • 자궁경부 세포검사 시장 점유율과 예측
  • HPV DNA 검사 시장 점유율과 예측

제5장 영국 시장 분석

  • 자궁경부암 검사 진찰자수
    • 자궁경부 세포검사
    • HPV DNA 검사
  • 자궁경부암에 의한 사망률
  • 자궁경부암 검사 시장 분석과 예측
    • 자궁경부암 검사
    • 자궁경부 세포검사
    • HPV DNA 검사

제6장 프랑스 시장 분석

  • 자궁경부암 검사 진찰자수
    • 자궁경부 세포검사
    • HPV DNA 검사
  • 자궁경부암에 의한 사망률
  • 자궁경부암 검사 시장 분석과 예측
    • 자궁경부암 검사
    • 자궁경부 세포검사
    • HPV DNA 검사

제7장 독일 시장 분석

  • 자궁경부암 검사 진찰자수
    • 자궁경부 세포검사
    • HPV DNA 검사
  • 자궁경부암에 의한 사망률
  • 자궁경부암 검사 시장 분석과 예측
    • 자궁경부암 검사
    • 자궁경부 세포검사
    • HPV DNA 검사

제8장 이탈리아 시장 분석

  • 자궁경부암 검사 진찰자수
    • 자궁경부 세포검사
    • HPV DNA 검사
  • 자궁경부암에 의한 사망률
  • 자궁경부암 검사 시장 분석과 예측
    • 자궁경부암 검사
    • 자궁경부 세포검사
    • HPV DNA 검사

제9장 스페인 시장 분석

  • 자궁경부암 검사 진찰자수
    • 자궁경부 세포검사
    • HPV DNA 검사
  • 자궁경부암에 의한 사망률
  • 자궁경부암 검사 시장 분석과 예측
    • 자궁경부암 검사
    • 자궁경부 세포검사
    • HPV DNA 검사

제10장 스웨덴 시장 분석

  • 자궁경부암 검사 진찰자수
    • 자궁경부 세포검사
    • HPV DNA 검사
  • 자궁경부암에 의한 사망률
  • 자궁경부암 검사 시장 분석과 예측
    • 자궁경부암 검사
    • 자궁경부 세포검사
    • HPV DNA 검사

제11장 스위스 시장 분석

  • 자궁경부암 검사 진찰자수
    • 자궁경부 세포검사
    • HPV DNA 검사
  • 자궁경부암에 의한 사망률
  • 자궁경부암 검사 시장 분석과 예측
    • 자궁경부암 검사
    • 자궁경부 세포검사
    • HPV DNA 검사

제12장 노르웨이 시장 분석

  • 자궁경부암 검사 진찰자수
    • 자궁경부 세포검사
    • HPV DNA 검사
  • 자궁경부암에 의한 사망률
  • 자궁경부암 검사 시장 분석과 예측
    • 자궁경부암 검사
    • 자궁경부 세포검사
    • HPV DNA 검사

제13장 네덜란드 시장 분석

  • 자궁경부암 검사 진찰자수
    • 자궁경부 세포검사
    • HPV DNA 검사
  • 자궁경부암에 의한 사망률
  • 자궁경부암 검사 시장 분석과 예측
    • 자궁경부암 검사
    • 자궁경부 세포검사
    • HPV DNA 검사

제14장 시장 성장 촉진요인

  • 세계적인 10대 성감염증 이환률 상승
  • 세계적인 HPV 감염 환자 증가

제15장 시장이 해결해야 할 과제

  • 세계적인 HPV 백신 프로그램 도입

도표

LSH 17.02.14

Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands) is 119 Page market research report with 115 Figures and 2 Tables published by Renub Research.

Cervical cancer is one of the most serious public health issues in Europe. Despite introduction of vaccination in 21 European countries, still more than 24 Thousand women have died from cervical cancer across all over Europe. Cervical cancer incidence rate in Europe was 10.6 per 100,000 women population. Germany, France and United Kingdom are top three dominating countries in the Europe cervical cancer market in 2015.

All the 9 countries in the report have been studied from 3 viewpoints.

Cervical Cancer Test Market, Population & Mortality

1. Cervical Cancer Test Population (2008-2020)

  • Pap Smear Test Population & Forecast
  • HPV DNA Test Population & Forecast

2. Cervical Cancer Mortality Population (2001-2011)

3. Cervical Cancer Test Market (2008-2020)

  • Pap Smear Test Market & Forecast
  • HPV DNA Test Market & Forecast

9 Countries studied in the report are as follows

  • 1. United Kingdom
  • 2. France
  • 3. Germany
  • 4. Italy
  • 5. Spain
  • 6. Sweden
  • 7. Switzerland
  • 8. Norway
  • 9. Netherlands

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 1000 paid databases.

Table of Contents

1. Executive Summary

2. Europe Cervical Cancer Test (Screening) Population & Forecast

3. Europe Cervical Cancer Test (Screening) Market & Forecast

  • 3.1 Europe Cervical Cancer Pap Smear Test (Screening) Market & Forecast
  • 3.2 Europe Cervical Cancer HPV DNA Test (Screening) Market & Forecast

4. Europe Cervical Cancer Test (Screening) Population Share, Market Share & Forecast

  • 4.1 Europe Cervical Cancer Test (Screening) Population Share & Forecast
  • 4.2 Europe Cervical Cancer Test (Screening) Market Share & Forecast
  • 4.3 Europe Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast
  • 4.4 Europe Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast

5. United Kingdom - Cervical Cancer Test Analysis

  • 5.1 United Kingdom Cervical Cancer Test (Screening) Population
    • 5.1.1 United Kingdom Cervical Cancer Pap Smear Test Population & Forecast
    • 5.1.2 United Kingdom Cervical Cancer HPV DNA Test Population & Forecast
  • 5.2 United Kingdom Cervical Cancer Deaths
  • 5.3 United Kingdom Cervical Cancer Test (Screening) Analysis
    • 5.3.1 United Kingdom Cervical Cancer Test Market & Forecast
    • 5.3.2 United Kingdom Pap Smear Test Market & Forecast
    • 5.3.3 United Kingdom HPV DNA Test Market & Forecast

6. France - Cervical Cancer Test Analysis

  • 6.1 France Cervical Cancer Test (Screening) Population
    • 6.1.1 France Cervical Cancer Pap Smear Test Population & Forecast
    • 6.1.2 France Cervical Cancer HPV DNA Test Population & Forecast
  • 6.2 France Cervical Cancer Mortality
  • 6.3 France Cervical Cancer Test (Screening) Analysis
    • 6.3.1 France Cervical Cancer Test Market & Forecast
    • 6.3.2 France Pap Smear Test Market & Forecast
    • 6.3.3 France HPV DNA Test Market & Forecast

7. Germany - Cervical Cancer Test Analysis

  • 7.1 Germany Cervical Cancer Test (Screening) Population
    • 7.1.1 Germany Cervical Cancer Pap Smear Test Population & Forecast
    • 7.1.2 Germany Cervical Cancer HPV DNA Test Population & Forecast
  • 7.2 Germany Cervical Cancer Mortality
  • 7.3 Germany Cervical Cancer Test (Screening) Market
    • 7.3.1 Germany Cervical Cancer Test Market & Forecast
    • 7.3.2 Germany Pap Smear Test Market & Forecast
    • 7.3.3 Germany HPV DNA Test Market & Forecast

8. Italy - Cervical Cancer Test Analysis

  • 8.1 Italy Cervical Cancer Test (Screening) Population
    • 8.1.1 Italy Cervical Cancer Pap Smear Test Population & Forecast
    • 8.1.2 Italy Cervical Cancer HPV DNA Test Population & Forecast
  • 8.2 Italy Cervical Cancer Mortality
  • 8.3 Italy Cervical Cancer Test (Screening) Market
    • 8.3.1 Italy Cervical Cancer Test Market & Forecast
    • 8.3.2 Italy Pap Smear Test Market & Forecast
    • 8.3.3 Italy HPV DNA Test Market & Forecast

9. Spain - Cervical Cancer Test Analysis

  • 9.1 Spain Cervical Cancer Test (Screening) Population
    • 9.1.1 Spain Cervical Cancer Pap Smear Test Population & Forecast
    • 9.1.2 Spain Cervical Cancer HPV DNA Test Population & Forecast
  • 9.2 Spain Cervical Cancer Mortality
  • 9.3 Spain Cervical Cancer Test (Screening) Market
    • 9.3.1 Spain Cervical Cancer Test Market & Forecast
    • 9.3.2 Spain Pap Smear Test Market & Forecast
    • 9.3.3 Spain HPV DNA Test Market & Forecast

10. Sweden - Cervical Cancer Test Analysis

  • 10.1 Sweden Cervical Cancer Test (Screening) Population
    • 10.1.1 Sweden Cervical Cancer Pap Smear Test Population & Forecast
    • 10.1.2 Sweden Cervical Cancer HPV DNA Test Population & Forecast
  • 10.2 Sweden Cervical Cancer Mortality
  • 10.3 Sweden Cervical Cancer Test (Screening) Market
    • 10.3.1 Sweden Cervical Cancer Test Market & Forecast
    • 10.3.2 Sweden Pap Smear Test Market & Forecast
    • 10.3.3 Sweden HPV DNA Test Market & Forecast

11. Switzerland - Cervical Cancer Test Analysis

  • 11.1 Switzerland Cervical Cancer Test (Screening) Population
    • 11.1.1 Switzerland Cervical Cancer Pap Smear Test Population & Forecast
    • 11.1.2 Switzerland Cervical Cancer HPV DNA Test Population & Forecast
  • 11.2 Switzerland Cervical Cancer Mortality
  • 11.3 Switzerland Cervical Cancer Test (Screening) Market
    • 11.3.1 Switzerland Cervical Cancer Test Market & Forecast
    • 11.3.2 Switzerland Pap smear Test Market & Forecast
    • 11.3.3 Switzerland HPV DNA Test Market & Forecast

12. Norway - Cervical Cancer Test Analysis

  • 12.1 Norway Cervical Cancer Test (Screening) Population
    • 12.1.1 Norway Cervical Cancer Pap Smear Test Population & Forecast
    • 12.1.2 Norway Cervical Cancer HPV DNA Test Population & Forecast
  • 12.2 Norway Cervical Cancer Mortality
  • 12.3 Norway Cervical Cancer Test (Screening) Market
    • 12.3.1 Norway Cervical Cancer Test Market & Forecast
    • 12.3.2 Norway Pap Smear Test Market & Forecast
    • 12.3.3 Norway HPV DNA Test Market & Forecast

13. Netherlands - Cervical Cancer Test Analysis

  • 13.1 Netherlands Cervical Cancer Test (Screening) Population
    • 13.1.1 Netherlands Cervical Cancer Pap Smear Test Population & Forecast
    • 13.1.2 Netherlands Cervical Cancer HPV DNA Test Population & Forecast
  • 13.2 Netherlands Cervical Cancer Mortality
  • 13.3 Netherlands Cervical Cancer Test (Screening) Market
    • 13.3.1 Netherlands Cervical Cancer Test Market & Forecast
    • 13.3.2 Netherlands Pap Smear Test Market & Forecast
    • 13.3.3 Netherlands HPV DNA Test Market & Forecast

14. Cervical Cancer Test Market Growth Drivers

  • 14.1 Rising Cases of Teenage Sexual Cases Globally
  • 14.2 Huge Prevalence of HPV Infected Patients Globally

15. Challenges in Cervical Cancer Test Market

  • 15.1 Introduction of HPV Vaccination Programs Globally

List of Figures

  • Figure 2 1: Europe - Cervical Cancer Test Population (Million), 2008 - 2015
  • Figure 2 2: Europe - Forecast for Cervical Cancer Test Population (Million), 2016 - 2020
  • Figure 3 1: Europe - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 3 2: Europe - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 3 3: Europe - Cervical Cancer Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 3 4: Europe - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 3 5: Europe - Cervical Cancer HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 3 6: Europe - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 4 1: Europe - Cervical Cancer Test Population Share (Percent), 2008 - 2015
  • Figure 4 2: Europe - Forecast for Cervical Cancer Test Population Share (Percent), 2016 - 2020
  • Figure 4 3: Europe - Cervical Cancer Test Market Share (Percent), 2008 - 2015
  • Figure 4 4: Europe - Forecast for Cervical Cancer Test Market Share (Percent), 2016 - 2020
  • Figure 4 5: Europe - Cervical Cancer Pap Smear Test Market Share (Percent), 2008 - 2015
  • Figure 4 6: Europe - Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2016 - 2020
  • Figure 4 7: Europe - Cervical Cancer HPV DNA Test Market Share (Percent), 2008 - 2015
  • Figure 4 8: Europe - Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2016 - 2020
  • Figure 5 1: United Kingdom - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 5 2: United Kingdom - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 5 3: United Kingdom - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 5 4: United Kingdom - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 5 5: United Kingdom - Cervical Cancer Deaths (Number), 2001 - 2011
  • Figure 5 6: United Kingdom - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 5 7: United Kingdom - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 5 8: United Kingdom - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 5 9: United Kingdom - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 5 10: United Kingdom - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 5 11: United Kingdom - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 6 1: France - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 6 2: France - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 6 3: France - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 6 4: France - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 6 5: France - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 6 6: France - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 6 7: France - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 6 8: France - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 6 9: France - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 6 10: France - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 6 11: France - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 7 1: Germany - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 7 2: Germany - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 7 3: Germany - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 7 4: Germany - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 7 5: Germany - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 7 6: Germany - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 7 7: Germany - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 7 8: Germany - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 7 9: Germany - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 7 10: Germany - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 7 11: Germany - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 8 1: Italy - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 8 2: Italy - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 8 3: Italy - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 8 4: Italy - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 8 5: Italy - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 8 6: Italy - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 8 7: Italy - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 8 8: Italy - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 8 9: Italy - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 8 10: Italy - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 8 11: Italy - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 9 1: Spain - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 9 2: Spain - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 9 3: Spain - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 9 4: Spain - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 -2020
  • Figure 9 5: Spain - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 9 6: Spain - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 9 7: Spain - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 9 8: Spain - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 9 9: Spain - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 9 10: Spain - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 9 11: Spain - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 10 1: Sweden - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 10 2: Sweden - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 10 3: Sweden - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 10 4: Sweden - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 10 5: Sweden - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 10 6: Sweden - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 10 7: Sweden - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 10 8: Sweden - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 10 9: Sweden - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 10 10: Sweden - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 10 11: Sweden - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 11 1: Switzerland - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 11 2: Switzerland - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 11 3: Switzerland - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 11 4: Switzerland - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 11 5: Switzerland - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 11 6: Switzerland - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 11 7: Switzerland - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 11 8: Switzerland - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 11 9: Switzerland - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 11 10: Switzerland - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 11 11: Switzerland - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 12 1: Norway - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 12 2: Norway - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 12 3: Norway - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 12 4: Norway - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 12 5: Norway - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 12 6: Norway - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 12 7: Norway - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 12 8: Norway - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 12 9: Norway - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 12 10: Norway - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 12 11: Norway - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 13 1: Netherlands - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 13 2: Netherlands - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 13 3: Netherlands - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 13 4: Netherlands - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 13 5: Netherlands - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 13 6: Netherlands - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 13 7: Netherlands - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 13 8: Netherlands - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 13 9: Netherlands - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 13 10: Netherlands - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 13 11: Netherlands - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020

List of Tables

  • Table 25 3: Worldwide - Prevalence (Percent) of Young Women (15-44 Years) who Have Sex before the Age of 15 Years, 1994 - 2006
  • Table 25 4: Worldwide - HPV Prevalence (Percent) among Women with Normal Cervical Cytology, 2010
Back to Top
전화 문의
이용안내
 
BCC Research